Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Physiol.

Sec. Cardiac Electrophysiology

Volume 16 - 2025 | doi: 10.3389/fphys.2025.1672433

Correction: Inhibition of EPAC1 signaling pathway alters atrial electrophysiology and prevents atrial fibrillation

Provisionally accepted
Bastien GuillotBastien Guillot1Arthur BoileveArthur Boileve2Richard David WaltonRichard David Walton1Caroline ConteCaroline Conte3Yannis Sainte-marieYannis Sainte-marie3Sabine CharronSabine Charron1Olivier BernusOlivier Bernus1Alice RecaldeAlice Recalde1Laurent SalléLaurent Sallé2Fabien BretteFabien Brette4*Frank Lezoualc'hFrank Lezoualc'h3
  • 1IHU Liryc Institut des Maladies du Rythme Cardiaque, Pessac, France
  • 2Universite de Caen Normandie, Caen, France
  • 3Institut des maladies metaboliques et cardiovasculaires, Toulouse, France
  • 4Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France

This article is a correction to:

  1. Inhibition of EPAC1 signaling pathway alters atrial electrophysiology and prevents atrial fibrillation

    1. Read original article

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

Correction on: Guillot B, Boileve A, Walton R, Harfoush A, Conte C, Sainte-Marie Y, Charron S, Bernus O, Recalde A, Sallé L, Brette F and Lezoualc'h F (2023) Inhibition of EPAC1 signaling pathway alters atrial electrophysiology and prevents atrial fibrillation. Front. Physiol. 14:1120336. doi: 10.3389/fphys.2023.1120336 In the published article, there was a mistake in the Funding statement. The funding statement for the ANR ELECTRO was displayed as "ANR-19-CE17-0010 (ELECTRO)". The correct statement is "ANR-20-CE17-0010 (ELECTRO).'' The original version of this article has been updated.

Keywords: EPAC, Atrial Fibrillation, optical mapping, cardiomyocytes, action potential

Received: 24 Jul 2025; Accepted: 28 Jul 2025.

Copyright: © 2025 Guillot, Boileve, Walton, Conte, Sainte-marie, Charron, Bernus, Recalde, Sallé, Brette and Lezoualc'h. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Fabien Brette, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material